CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 155 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $59,071,924 | -11.6% | 2,551,703 | 0.0% | 8.50% | -18.4% |
| Q4 2022 | $66,854,619 | +33.3% | 2,551,703 | 0.0% | 10.41% | +20.2% |
| Q3 2022 | $50,166,000 | +12.4% | 2,551,703 | 0.0% | 8.66% | -27.3% |
| Q2 2022 | $44,629,000 | +101.1% | 2,551,703 | +88.1% | 11.91% | +148.3% |
| Q1 2022 | $22,188,000 | +172.1% | 1,356,250 | +171.2% | 4.80% | +202.3% |
| Q4 2021 | $8,155,000 | – | 500,000 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |